Publications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (48)


  1. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347

  2. Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer

    Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 796-807

  3. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence

    European Journal of Internal Medicine, Vol. 100, pp. 33-45

  4. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

    Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661

  5. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis

    European Journal of Internal Medicine, Vol. 105, pp. 30-37

  6. Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study

    European Journal of Cancer, Vol. 165, pp. 136-145

  7. The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair

    Cancers, Vol. 14, Núm. 12

  8. Treatment modalities in cancer-associated venous thromboembolism (VTE)

    Best Practice and Research: Clinical Haematology, Vol. 35, Núm. 1

  9. Venous thromboembolism incidence in cancer patients with germline BRCA mutations

    Clinical and Translational Oncology, Vol. 24, Núm. 1, pp. 154-158

  10. Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need

    Thrombosis Update, Vol. 6